An international cluster of 117 researchers from 50 countries has arrived at a consensus on six principles that, in the team’s considered view, ought to guide the use of AI across healthcare worldwide. 

Standing FDA guidance reflects concern over physicians deferring to AI-aided CDS recommendations when pressed for time or uncertain of their own judgments. Is that stance outdated? 

A new post-stroke care pathway from Viz.ai and Medtronic is associated with significant benefits, including higher patient and clinician satisfaction.

People are still asking if AI will replace doctors or other healthcare workers. 

Last summer more than 40% of 121 hospital executives surveyed said their organization had already realized a decent ROI in generative AI. However, a C-suite slice of nearly the same size said it was too soon to know for sure. 

Don’t judge DeepSeek on the innovativeness of its programming. Judge it on the degree to which it shakes up the economics of the AI market.

Medical students are broadly familiar with digital health technologies. Relatedly, they believe AI will play a crucial role in the future of healthcare. These are good signs for the advancement of evidence-based medicine. 

Last week’s blastoff of the Chinese AI company DeepSeek struck many like a cold bucket of water in the face.